Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis

作者: S Jagadeeshan , YR Krishnamoorthy , M Singhal , A Subramanian , J Mavuluri

DOI: 10.1038/ONC.2013.576

关键词:

摘要: Pancreatic ductal adenocarcinoma (PDAC) is the eighth largest cause of cancer-related mortality across world, with a median 5-year survival rate less than 3.5%. This partly because molecules and molecular mechanisms that contribute to PDAC are not well understood. Our goal understand role p21-activated kinase 1 (Pak1) signaling axis in progression PDAC. Pak1, serine/threonine kinase, well-known regulator cytoskeletal remodeling, cell motility, proliferation survival. Recent reports suggest Pak1 by itself can have an oncogenic wide variety cancers. In this study, we analyzed expression human pancreatic cancer tissues found levels significantly upregulated samples as compared adjacent normals. Further, study functional model systems, developed stable overexpression lentiviral short hairpin RNA-mediated knockdown (KD) clones studied changes transforming properties cells. We also observed KD failed form tumors nude mice. By adopting quantitative PCR array-based approach, identified fibronectin, component extracellular matrix mesenchymal marker, transcriptional target signaling. The underlying mechanism Pak1-mediated transformation includes its nuclear import recruitment fibronectin promoter via interaction factor-κB (NF-κB)–p65 complex. To our knowledge, first illustrating Pak1–NF-κB–p65-mediated regulation potent tumor-promoting KRAS intact model.

参考文章(32)
Christy C. Ong, Adrian M. Jubb, Wei Zhou, Peter M. Haverty, Adrian L. Harris, Marcia Belvin, Lori S. Friedman, Hartmut Koeppen, Klaus P. Hoeflich, p21-activated kinase 1: PAK’ed with potential Oncotarget. ,vol. 2, pp. 491- 496 ,(2011) , 10.18632/ONCOTARGET.271
Luis E. Arias-Romero, Jonathan Chernoff, A tale of two Paks Biology of the Cell. ,vol. 100, pp. 97- 108 ,(2008) , 10.1042/BC20070109
Raymond E Menard, Raymond R Mattingly, Cell surface receptors activate p21-activated kinase 1 via multiple Ras and PI3-kinase-dependent pathways Cellular Signalling. ,vol. 15, pp. 1099- 1109 ,(2003) , 10.1016/S0898-6568(03)00087-1
C. C. Ong, A. M. Jubb, P. M. Haverty, W. Zhou, V. Tran, T. Truong, H. Turley, T. O'Brien, D. Vucic, A. L. Harris, M. Belvin, L. S. Friedman, E. M. Blackwood, H. Koeppen, K. P. Hoeflich, Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 7177- 7182 ,(2011) , 10.1073/PNAS.1103350108
Diana Zi Ye, Jeffrey Field, PAK signaling in cancer Cellular logistics. ,vol. 2, pp. 105- 116 ,(2012) , 10.4161/CL.21882
Eithne Costello, William Greenhalf, John P. Neoptolemos, New biomarkers and targets in pancreatic cancer and their application to treatment. Nature Reviews Gastroenterology & Hepatology. ,vol. 9, pp. 435- 444 ,(2012) , 10.1038/NRGASTRO.2012.119
John P. Morris, Sam C. Wang, Matthias Hebrok, KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nature Reviews Cancer. ,vol. 10, pp. 683- 695 ,(2010) , 10.1038/NRC2899
Beatriz Sánchez-Solana, Mona Motwani, Da-Qiang Li, Jeyanthy Eswaran, Rakesh Kumar, p21-activated Kinase-1 Signaling Regulates Transcription of Tissue Factor and Tissue Factor Pathway Inhibitor Journal of Biological Chemistry. ,vol. 287, pp. 39291- 39302 ,(2012) , 10.1074/JBC.M112.404061
Martin E. Fernandez-Zapico, Natalia C. Gonzalez-Paz, Ellen Weiss, Doris N. Savoy, Julian R. Molina, Rafael Fonseca, Thomas C. Smyrk, Suresh T. Chari, Raul Urrutia, Daniel D. Billadeau, Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis Cancer Cell. ,vol. 7, pp. 39- 49 ,(2005) , 10.1016/J.CCR.2004.11.024
Rong Wu, Allan L. Abramson, Marc H. Symons, Bettie M. Steinberg, Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression. International Journal of Cancer. ,vol. 127, pp. 2230- 2237 ,(2010) , 10.1002/IJC.25226